MENU

News

Latest News Articles

News

08.06.20

Ofatumumab Reduced Annualized Relapse Rate in MS in Phase 3 Clinical Trials 
  • KEYWORDS:
  • Multiple sclerosis
  • Ofatumumab
  • Relapsing Multiple Sclerosis

News

08.05.20

The Rapid Arterial Occlusion Evaluation (RACE) Scale Validated in First Study for Stroke Triage 
  • KEYWORDS:
  • Rapid Arterial Occlusion Evaluation
  • Stroke
  • Stroke outcomes

News

08.05.20

DHODH Inhibitor Reduces Lesions Significantly in Relapsing-Remitting MS
  • KEYWORDS:
  • Multiple sclerosis
  • Relapsing Multiple Sclerosis

News

08.04.20

First Participants Enrolled in Trial of Nanocrystalline Gold for Treatment of ALS
  • KEYWORDS:
  • Amyotrophic Lateral Sclerosis
  • Gold nanocrystal

News

08.03.20

FDA Approves ppCBD to Treat Seizures Associated with Tuberous Sclerosis Complex
  • KEYWORDS:
  • Cannabidiol
  • FDA Approvals
  • Seizures
  • Tuberous Sclerosis Complex

News

07.31.20

Alzheimer Disease Risk May Be Measurable in Adolescence and Early Adulthood 
  • KEYWORDS:
  • Alzheimer Disease
  • Dementia
  • Early onset Alzheimer disease

News

07.30.20

Blood Tests for Alzheimer Disease Advance
  • KEYWORDS:
  • Alzheimer Disease
  • Dementia

News

07.29.20

Flu and Pneumonia Vaccination Correlates With Reduced Incidence of Alzheimer Disease
  • KEYWORDS:
  • Alzheimer Disease
  • Early onset Alzheimer disease
  • Vaccines

News

07.28.20

Plasmapheresis With Albumin Delays Cognitive and Functional Declines in Clinical Trial for Alzheimer Disease
  • KEYWORDS:
  • Alzheimer Disease
  • Early onset Alzheimer disease
  • Plasmapheresis With Albumin

News

07.27.20

Studies Show the Varying Risks of Stroke in Individuals with COVID-19
  • KEYWORDS:
  • Coronavirus
  • COVID-19
  • Ischemic stroke
  • Stroke

News

07.24.20

FDA-Cleared Mobile Brain Assessment Tool for Pre-Sport Cognitive Measurement 
  • KEYWORDS:
  • FDA Clearance
  • TBI
  • traumatic brain injury
TBI

News

07.22.20

FDA Approves New Oxybates Compound for Cataplexy or Excessive Daytime Sleepiness of Narcolepsy
  • KEYWORDS:
  • Excessive daytime sleepiness
  • FDA Approvals
  • Sleep
  • Sleep disorders
  • Xywav

News

07.21.20

FDA Accepts Supplemental New Drug Application for Pimavanserin for Dementia-Related Psychosis Symptoms 
  • KEYWORDS:
  • Alzheimer Disease
  • Dementia
  • FDA Approvals
  • Parkinson disease
  • Pimavanserin

News

07.21.20

First Participant Receives Bemcentinib in Recurrent Glioblastoma Phase 1/2 Study
  • KEYWORDS:
  • bemcentinib
  • BGB324
  • Glioblastoma
  • Neuro-oncology

News

07.20.20

Parkinson's Disease and COVID-19 Patient Reported Outcomes on Fox Insight
  • KEYWORDS:
  • Coronavirus
  • COVID-19
  • Movement disorders
  • Parkinson disease
Show More
This Month's Issue
Palliative Neurology

Jessica M. Baker, MD

Pompe Disease

Jonathan Cauchi, MD

Muscle MRI for Neuromuscular Disorders

Stefan Nicolau, MD, and Elie Naddaf, MD